Furthermore, the decrease in IL37 expression accompanied by MCC950 treatment also resulted in reduced IL1β expression, further verifying that elevated IL37 serves as a self‐protective mechanism for tumour cells against inflammation. This evidence concerns the gene IL1B and neoplasm.